Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Tango Therapeutics Inc

TNGX
2,47
-0,04 (-1,59%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202502:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202501:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202501:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202513:00GLOBETango Therapeutics to Present at the Guggenheim SMID Cap..
13/1/202513:30EDGAR2Form 8-K - Current report
02/1/202513:07EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
03/12/202413:00BWTango Therapeutics Announces Inducement Grants Under Nasdaq..
27/11/202413:00BWTango Therapeutics to Present at the Piper Sandler 36th..
20/11/202422:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
19/11/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202403:35EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/11/202403:40EDGAR2Form 144 - Report of proposed sale of securities
06/11/202413:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:23EDGAR2Form 8-K - Current report
06/11/202413:05BWTango Therapeutics Reports Third Quarter 2024 Financial..
06/11/202413:00BWTango Therapeutics Reports Positive TNG462 Clinical Data and..
28/10/202414:22EDGAR2Form SC 13D/A - General Statement of Acquisition of..
26/10/202403:30EDGAR2Form 144 - Report of proposed sale of securities
23/10/202402:50EDGAR2Form 144 - Report of proposed sale of securities
22/10/202418:03EDGAR2Form 144 - Report of proposed sale of securities
28/8/202413:00BWTango Therapeutics to Participate in Upcoming Investor..
07/8/202413:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:07EDGAR2Form 8-K - Current report
07/8/202413:00BWTango Therapeutics Reports Second Quarter 2024 Financial..
07/6/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 8-K - Current report
05/6/202413:00BWTango Therapeutics to Present at the Goldman Sachs 45th..
23/5/202415:18PRNUSMedivir´s licensee, Tango Therapeutics, has discontinued..
23/5/202413:18EDGAR2Form 8-K - Current report
23/5/202413:00BWTango Therapeutics Announces Discontinuation of TNG348..
08/5/202413:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:14EDGAR2Form 8-K - Current report
08/5/202413:00BWTango Therapeutics Reports First Quarter 2024 Financial..
01/4/202422:48BWTango Therapeutics Announces Inducement Grants Under Nasdaq..
18/3/202412:00BWTango Therapeutics Reports Fourth Quarter and Full Year 2023..
06/3/202413:00BWTango Therapeutics to Participate in Upcoming Investor..
05/3/202422:47GLOBETango Therapeutics to Highlight Preclinical Data on..
Apertura: 2,54 Min: 2,45 Max: 2,70
Chiusura: 2,51

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network